Search results
Results from the WOW.Com Content Network
In 1929, Wallenberg received the Erb Commemorative Medal for his work in the field of anatomy, physiology and pathology of the nervous system. [8] Wallenberg's first patient in 1885 was a 38-year-old male with symptoms of vertigo, numbness, loss of pain and temperature sensitivity, paralysis of multiple locations, ataxia and more. His ...
Cerebral infarction, also known as an ischemic stroke, is the pathologic process that results in an area of necrotic tissue in the brain (cerebral infarct). [1] In mid to high income countries, a stroke is the main reason for disability among people and the 2nd cause of death. [2]
The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. [2] Hypertension (high blood pressure) is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis . [ 5 ]
Researchers found that every change in these indicators was linked to an increased stroke risk of 10-19%. Changes to the three caliber indicators in the “fingerprint” were correlated to a 10 ...
The annual new detection rate incidence of AVMs is approximately 1 per 100,000 a year. The point prevalence in adults is approximately 18 per 100,000. [ 3 ] AVMs are more common in males than females, although in females pregnancy may start or worsen symptoms due to the increase in blood flow and volume it usually brings. [ 31 ]
Analysis of data from this trial has indicated a 7% lower eight-year mortality rate with coiling, [33] a high rate of aneurysm recurrence in aneurysms treated with coiling—from 28.6 to 33.6% within a year, [34] [35] a 6.9 times greater rate of late retreatment for coiled aneurysms, [36] and a rate of rebleeding 8 times higher than surgically ...
Eventually, researchers began to apply his technique to stroke patients, and it came to be called constraint-induced movement therapy. Notably, the initial studies focused on chronic stroke patients who were more than 12 months past their stroke. This challenged the belief held at that time that no recovery would occur after one year.
If the patient is 'low risk' using the CHA 2 DS 2-VASc score (that is, 0 in males or 1 in females), no anticoagulant therapy is recommended. In males with 1 stroke risk factor (that is, a CHA 2 DS 2-VASc score=1), antithrombotic therapy with OAC may be considered, and people's values and preferences should be considered. [24]